HITLAB Announces Winners of Fall 2023 Breakthrough Alliance Challenge

HelixVM™: Randomized Clinical Trial Demonstrates Marketplace’s Ability to Advance Healthcare Access with Improved Provider Capacity

HITLAB Hosts Fall 2023 Innovators Summit: Breakthroughs and Roadblocks -Exploring Digital Health’s Trajectory through Research & Evidence

Metfora and HITLAB Collaborate to Revolutionize Chronic Disease Diagnosis

HITLAB Announces Finalists for Fall 2023 Breakthrough Alliance Challenge

HITLAB Expands Breakthrough Alliance Board with the addition of Dr. Glennis Mehra, Director Biolabs at NYU Langone

Clinical Trial Adherence Intelligence

Curio Digital Therapeutics: Pivotal Trial for Postpartum Depression Digital Therapeutic Meets Efficacy Endpoints

HITLAB Welcomes Laurent van Lerberghe as New Board Member of Breakthrough Alliance and Chairman of Board for Europe